Mark R. has over 20 years of experience in Health Economics and Outcomes Research (HEOR) and Market Access, with a focus on immunization and infectious diseases. They earned a Ph.D. in Health Economics from the University of Groningen, conducting significant research on the cost-effectiveness of interventions against diseases like pneumococcal infections. Mark held various roles at Pfizer, culminating in the position of US & Global Value and Evidence Team Lead for Pneumococcal Vaccines. They have published over 35 scientific papers and served as an editorial board member for the journal Vaccine while also contributing to public health through research fellowships and advisory roles.
This person is not in the org chart
This person is not in any teams
This person is not in any offices